Shilpa Medicare shares zoomed over 4% after the company announced that it has received an Establishment Inspection Report (EIR) for the Bengaluru unit from the USFDA. At around 2.06 PM, Shilpa ...

Shilpa Medicare share price gained in trade after the company announced a positive regulatory update from the US health ...

Karnataka: Shilpa Medicare Limited has received an Establishment Inspection Report (EIR) with Voluntary Action Indicated (VAI ...

Shilpa Medicare added 2.94% to Rs 920.70 after the company announced that its Unit VI facility in Dabaspet, Bengaluru, Karnataka, has received EIR with VAI (Voluntary Action Indicated) classification ...

The company, in an exchange filing on July 16, said that Unit VI, Dabaspet, Bengaluru, Karnataka, India, has received an EIR with VAI (Voluntary Action Indicated) classification from the US FDA.

Shilpa Medicare's facility in Bengaluru is capable of manufacturing, packaging, testing, storage and distribution of two ...

Shilpa Medicare's Unit VI facility, located at Dabaspet, Bengaluru, Karnataka, has received SFDA, Saudi Arabia, GMP certification.

Karnataka: Shilpa Medicare has announced that its Unit VI facility, located at Dabaspet, Bengaluru, Karnataka, has received ...

The company’s subsidiary, Shilpa Pharma Lifesciences’ Unit-1, has completed a GMP inspection by the Brazilian regulatory ...

The inspection, conducted by Brazilian regulatory authority ANVISA, was held between June 30 and July 4. Earlier, it had ...

The personal information of more than 100,000 Medicare recipients may have been compromised in a recent "data incident," the Centers for Medicare & Medicaid Services said June 30. As a result ...

Pharmaceutical companies are pushing to disrupt the recently passed Medicare Drug Price Negotiation Program. Learn how AARP is fighting to protect it.